http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60208554-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cfefec38a26d667af525feb9d4f919f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 2002-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6631e9411c83c2793a2fcbf00d81ef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c18c8cb8b63ee349c32cddb48a61c70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa083193f71b7ee69e0b2c4c57c0d87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2947b862ae499bf0bea99fd7fb00a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3574bdf17a4a31292f0892fc62ddbe02
publicationDate 2006-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60208554-T2
titleOfInvention NEW ALIPHATIC COMPOUND, SYNTHESIS METHOD AND USE METHOD
abstract Fatty acid amide derivatives (I) are new. Fatty acid amide derivatives of formula (I) and their stereoisomers and salts are new. [Image] A : C nH (2n-2m)-CH 3; n : 4-22; m : number of unsaturated bonds and is 0-7; l : 0-10; s : 0; p+q : 4-5; or s : 1; and p+q : 3-4; R : 1-10C alkyl; and R AH or 1-10C alkyl. ACTIVITY : Antiaggregant; Antiinflammatory; Cardiant; Antiarteriosclerotic; Cerebroprotective; Vasotropic; Thrombolytic; Antianginal; Hepatotropic; Antilipemic. MECHANISM OF ACTION : Cytokine-Antagonist; TNF-Antagonist-alpha ; PDGF-Antagonist; Cholesterol-Antagonist. In assays, (4Z,7Z,10Z,13Z,16Z,19Z)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]docosahexaenamide (Ia) inhibited platelet aggregation with an IC 5 0 of 1.5 MicroM, compared to 5.0 MicroM for indomethacin.
priorityDate 2001-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467805060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466889891

Total number of triples: 32.